2.28
price up icon0.00%   0.00
 
loading

Gt Biopharma Inc Aktie (GTBP) Neueste Nachrichten

pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily

Apr 25, 2025
pulisher
Apr 09, 2025

Nanobodies Market Growth, Opportunities and Future Scope 2025-2032 | Merck KGaA, Sanofi, AlpalifeB Inc - newstrail.com

Apr 09, 2025
pulisher
Apr 08, 2025

TIBSOVO's Continued Success Solidifies Its Position as a Leader in IDH1 Mutant Space | DelveInsight - The Malaysian Reserve

Apr 08, 2025
pulisher
Apr 08, 2025

GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak - MSN

Apr 08, 2025
pulisher
Apr 05, 2025

GT Biopharma Issues Warrant to Cytovance for Services Rendered - Investing.com Australia

Apr 05, 2025
pulisher
Apr 04, 2025

GT Biopharma Issues Warrant to Cytovance for Services Rendered By Investing.com - Investing.com Canada

Apr 04, 2025
pulisher
Apr 01, 2025

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Cue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 31, 2025
pulisher
Mar 24, 2025

North American Morning Briefing : Stock Futures -2- - MarketScreener

Mar 24, 2025
pulisher
Mar 18, 2025

GT Biopharma (GTBP) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Nanobodies Market Detailed In New Research Report 2025 | Sanofi, - openPR

Mar 17, 2025
pulisher
Mar 13, 2025

Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 13, 2025
pulisher
Mar 11, 2025

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - MarketBeat

Mar 11, 2025
pulisher
Mar 10, 2025

The Goodyear Tire & Rubber Company (GT): A Bull Case Theory - Yahoo Finance

Mar 10, 2025
pulisher
Mar 04, 2025

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Can GT Biopharma's TriKE® Technology Transform Blood Cancer Treatment? Phase 1 Trial Updates Coming in 2025 - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

GT Biopharma Launches Shareholder Communications Initiative - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 01, 2025

Roth Capital Has Weak Forecast for GT Biopharma Q1 Earnings - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Analysts Issue Forecasts for GT Biopharma FY2029 Earnings - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

GT Biopharma Announces Dosing Of New Patient In GTB-3550 TriKE(TM) Phase I/II Clinical Trial - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

GT Biopharma Announces $7.1 Million Convertible Debt Financing - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 25, 2025

GT Biopharma Announces Exercise of Warrants - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

"Signal Advance, Inc. (OTC: SIGL) Achieves Technology - openPR

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma announces warrant exercise, plans new offering - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma announces warrant exercise, plans new offering By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

GTBPGt Biopharma Inc Latest Stock News & Market Updates - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn

Feb 25, 2025
pulisher
Feb 25, 2025

Artificial Intelligence (AI) News Live Feed - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma withdraws SEC registration statement - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma Pulls Back S-1 Filing: What Does This Mean for Their Financing Strategy? - StockTitan

Feb 25, 2025
pulisher
Feb 21, 2025

GT Biopharma, Inc. SEC 10-K Report - TradingView

Feb 21, 2025
pulisher
Feb 19, 2025

This New Nasdaq Biotech Could Revolutionize Emergency Cardiac CareHere's Why - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

Short Interest in GT Biopharma, Inc. (NASDAQ:GTBP) Expands By 5.1% - Defense World

Feb 19, 2025
pulisher
Feb 15, 2025

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven - Yahoo Finance

Feb 15, 2025
pulisher
Feb 06, 2025

GT Biopharma Announces Recently Presented Data on Our Next Generation TriKE (OXS-C3550) at The Ash Meeting in Atlanta, GA - ACCESS Newswire

Feb 06, 2025
pulisher
Feb 05, 2025

Nanobodies Market Analysis: Growth Drivers in Targeted - openPR

Feb 05, 2025
pulisher
Feb 04, 2025

Pre-market Movers In Healthcare Sector: HUGE, ONTX, SVRA, CELC, CHFS... - RTTNews

Feb 04, 2025
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):